Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barboza relinquishes reign of Brazilian giant DASA

This article was originally published in Clinica

Executive Summary

Marcelo Noll Barboza has resigned as director-president of Diagn�sticos da América (DASA), the Brazilian diagnostic services and hospital and laboratory supplies giant. From 27 April, board chairman Romeu Côrtes Domingues will take over in an interim capacity for up to 180 days, while a replacement is appointed. Mr Barboza, who had led for three-and-a-half years, will continue to serve the company in an advisory role “for up to two years”. The Barueri, São Paulo-based group, which last week posted a 13% hike in full-year revenues for 2011 (www.clinica.co.uk, 27 March 2012), also announced the appointment of Carlos Elder Maciel de Aquino as financial director, and Paulo Bokel Catta-Preta as director of investor relations.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT098736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel